Basophil recruitment and IL-4 production during human allergen-induced late asthma

Abstract

Background: Basophils represent an important source of inflammatory mediators and cytokines after IgE-dependent activation in human beings. Objective: To assess the role of basophils in allergic asthma, we measured the number of basophils in the bronchial mucosa and their capacity to express IL-4 mRNA and protein during allergen-induced late asthmatic responses. Methods: Fiberoptic bronchoscopic bronchial biopsies were obtained at 24 hours from sites of segmental bronchial allergen challenge and control sites in 19 patients with atopic asthma and 6 nonatopic healthy volunteers. Basophil numbers were assessed by immunohistochemistry through use of mAb 2D7. IL-4 mRNA–positive cells were detected through use of in situ hybridization and colocalized to basophils through use of sequential immunohistochemistry/in situ hybridization. IL-4 protein was detected and colocalized to basophils through use of dual immunohistochemistry. Results: After allergen challenge, there was an increase in the median number of 2D7-positive basophils per square millimeter in the bronchial mucosa in patients with asthma (0.9 cells/mm2 at baseline to 8.8 cells/mm2 after challenge; P = .002), which also was significantly higher than what was seen in nonasthmatic controls (P = .01). Similarly, IL-4 mRNA– positive cells were increased at 24 hours in patients with asthma (1.4 to 14) in comparison with controls (0 to 0; P = .02). Colocalization studies revealed that 15% and 41% of the basophil population in patients with asthma after allergen-challenge expressed, respectively, IL-4 mRNA and protein. Conversely, 19% of IL-4 mRNA–positive cells and 72% of IL-4 protein–positive cells were accounted for by basophils. Conclusion: After allergen provocation in sensitive patients with atopic asthma, basophils are recruited to the bronchial mucosa and express IL-4 mRNA and protein, which might contribute to local IgE synthesis and/or tissue eosinophilia or other aspects of allergic inflammation during late responses and ongoing asthma. (J Allergy Clin Immunol 2001;108:205-11.)